Both in R&D — Physical & Biological Sciences
MaxCyte vs bioAffinity Technologies
Over the past year MXCT returned −13.7% and BIAF returned −90.7%; their daily moves had a correlation of 0.02.
MXCT −13.7% BIAF −90.7%Growth of $1, one year, split-adjusted
| Metric | MXCT | BIAF |
|---|---|---|
| Price | $1.39 | $2.93 |
| Market cap | $143.5M | $1.8M |
| Today | −4.79% | −8.15% |
| 1 month | +27.5% | −51.7% |
| 6 months | +64.2% | −90.1% |
| Year to date | −10.3% | −83.4% |
| 1 year | −13.7% | −91.5% |
| Revenue growth (YoY) | −14.5% | +19.0% |
| Gross margin | 77.0% | 100.0% |
| Net margin | −122.0% | −222.8% |
| P/E (TTM) | — | — |
| Price / sales | 4.6× | 0.3× |
| Net cash | $105.7M | $1.8M |
| Dividend yield | — | — |
| Volatility (60d) | 82.3% | 826.0% |
| Short % of float | 2.0% | 11.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).